Skip to main content
WLKP $21.70 +0.14%
WLKP logo

WLKP · Westlake Chemical Partners LP

Track WLKP — free
$21.70 +0.03 (+0.14%) At close · Aug 14
Market Cap
$777.52M
Shares
35.25M
All earnings calls

Earnings call · FY2025 Q4

Westlake Chemical Partners LP Q4 FY2025 Earnings Call

Westlake Chemical Partners LP Q4 FY2025 Earnings Call

Concluded Feb 24, 2026 Audio replay Verified speakers
Feb 24, 2026 18:19 15 turns
Period
FY2025 Q4
Runtime
18:19
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Westlake Chemical Partners reported Q4 2025 net income attributable to the Partnership of $14.5 million ($0.41/unit) with MLP distributable cash flow of $18.8 million and a 1.13x coverage ratio, while full-year 2025 net income fell to $48.7 million from $62.4 million in 2024 due to the planned Petro 1 turnaround, and declared its 46th consecutive quarterly distribution of $0.4714/unit.

Westlake parent sponsorship and contract renewal 26 Petro One turnaround and production volumes 21 Quarterly distributions and coverage 17 Stable fee-based cash flow and ethylene sales agreement 16 2026 outlook and recovery in DCF 14 Balance sheet and liquidity 10

Management tone

Positive

Net tone +45 · moderate hedging

Grounding quotes
  • “The stability of our business model and associated cash flows demonstrate the benefit that our ethylene sales agreement and its protective provisions provide the partnership through predictable, long-term earnings and cash flows.”
  • “we expect the absence of any turnarounds in 2026 to result in solid production and sales volume growth that should drive a recovery in a distributable cash flow and coverage ratio back to historical levels”
  • “Our distribution coverage for the full year of 2025 was 0.8 times.”
  • “we are able to sustain our current distribution without the need to access the capital markets”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $323.05M +11.4% YoY
Gross margin · derived Q4 30.0% -4.0 pp YoY
Net income · derived Q4 $14.54M -3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Q4 2025 coverage ratio of 1.13x described as the highest quarterly coverage ratio since Q4 2022
  • Ethylene sales agreement with Westlake renewed through 2027 with no changes to contract terms
  • No planned turnarounds in 2026, expected to drive higher production and sales volume and coverage ratio recovery
  • 46th consecutive quarterly distribution declared at $0.4714/unit with no reductions since the 2014 IPO
  • Consolidated leverage ratio below 1x with operating surplus of approximately $74 million at end of 2025

Risks & pressure points

  • Full-year 2025 net income attributable to the Partnership fell $13.7 million to $48.7 million from $62.4 million in 2024 due to the Petro 1 turnaround
  • Full-year 2025 MLP distributable cash flow declined $13.5 million to $53.4 million from $66.9 million in 2024
  • Full-year 2025 distribution coverage of 0.8x, below the 1.1x target
  • Full-year 2025 cash flows from operating activities dropped $204.5 million to $280.5 million due to Petro 1 turnaround spending
  • Full-year 2025 maintenance capital expenditures of $79 million at Opco
  • Investment and management agreement cash balance drawn down during 2025 to fund turnaround and distributions

Key moments

Jump directly to management's words in the synchronized transcript.

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$0.47
Full-screen source Call document